Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan in non-obstructive hypertrophic cardiomyopathy
NCT00430833Phase 2Unknown
- Sponsor
- Charles University
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan in hypertrophic cardiomyopathy (HCM), sponsored by Charles University. Status: unknown.
02
Drugs
candesartan
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT00430833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430833.